COMMUNIQUÉS West-GlobeNewswire

The Hemp Doctor Unveils New 1G Liquid Diamond Disposable 75% THCA Vape

11/10/2024 - 16:52

MOORESVILLE, N.C., Oct. 11, 2024 (GLOBE NEWSWIRE) -- The Hemp Doctor, a leader in high-quality hemp products, is excited to announce the launch of its newest innovation: the 1G Liquid Diamond Disposable THCA Vape . [...]

ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA

11/10/2024 - 15:43

ANNOUNCEMENT NO. 278 11 October 2024 ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA As mentioned in company announcement no. 276, ChemoMetec has made an indicative purchase offer for the Belgian company [...]

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

11/10/2024 - 15:31

HOUSTON, Oct. 11, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

11/10/2024 - 15:20

Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule [...]

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

11/10/2024 - 15:15

-Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD- -Improvements Seen in Multiple Cardiac and Skeletal Endpoints Demonstrating Stabilization of Cardiac and Skeletal Muscle Function Over 3 Years [...]

PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing

11/10/2024 - 15:05

Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia SINGAPORE, Oct. 11, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a [...]

NEXGEL to Participate in Upcoming October Investor Conferences

11/10/2024 - 15:00

LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

11/10/2024 - 15:00

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]

INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit

11/10/2024 - 14:30

Boca Raton, Florida, Oct. 11, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc . (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company targeting microglial activation and neuroinflammation as a [...]

23andMe Announces 1-for-20 Reverse Stock Split

11/10/2024 - 14:15

SUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today that the 1-for-20 reverse stock split of the Company’s Class A and Class B common stock [...]

MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024

11/10/2024 - 14:05

ROCKVILLE, Md., Oct. 11, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]

Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis for Second Consecutive Year

11/10/2024 - 14:00

Nelipak Ranked Among the Top 15% of Surveyed Companies CRANSTON, R.I., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading global manufacturer of packaging solutions for medical device, [...]

Alignment Healthcare Continues to Deliver High-Quality Medicare Advantage Plans, 4 Stars or Greater for 98% of Members in 2025

11/10/2024 - 14:00

Medicare Advantage company retains 5- out of 5-star rating in North Carolina and Nevada, California PPO earns 4.5 stars ORANGE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) [...]

Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

11/10/2024 - 14:00

WATERTOWN, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/10/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best [...]

Auron Announces Poster Presentation at 2024 PCF Annual Scientific Retreat

11/10/2024 - 14:00

NEWTON, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics , a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, [...]

InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference

11/10/2024 - 14:00

Investments in People, Processes and Tools Deliver Enhanced Experience for InnovAge Participants at Company’s 20 Centers DENVER, Oct. 11, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a [...]

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

11/10/2024 - 14:00

LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

11/10/2024 - 13:35

MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]